COVID severity test ( CoST sensor)—An electrochemical immunosensing approach to stratify disease sev...
COVID severity test ( CoST sensor)—An electrochemical immunosensing approach to stratify disease severity
About this item
Full title
Author / Creator
Publisher
Hoboken: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
With the evolution of the COVID‐19 pandemic, there is now a need for point‐of‐care devices for the quantification of disease biomarkers toward disease severity assessment. Disease progression has been determined as a multifactor phenomenon and can be treated based on the host immune response within each individual. CoST is an electrochemical immuno...
Alternative Titles
Full title
COVID severity test ( CoST sensor)—An electrochemical immunosensing approach to stratify disease severity
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a6d9690a76064a1fac3e1f1e5a1cbe0d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a6d9690a76064a1fac3e1f1e5a1cbe0d
Other Identifiers
ISSN
2380-6761
E-ISSN
2380-6761
DOI
10.1002/btm2.10566
